Camden National Bank Abbott Laboratories Transaction History

Camden National Bank

$552 Million
Q1 2024

A detailed history of Camden National Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Camden National Bank holds 3,738 shares of ABT stock, worth $382,509. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,738

Previous 4,165 10.25%

Holding current value

$382,509

Previous $458,000 7.42%

% of portfolio

0.08%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $46,765 - $51,649	-427 Reduced 10.25%	3,738 $424,000
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $28,950 - $35,438	-321 Reduced 7.16%	4,165 $458,000
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $14,425 - $17,307	-151 Reduced 3.26%	4,486 $434,000
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $9,674 - $10,779	96 Added 2.11%	4,637 $505,000
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $159,044 - $187,204	-1,642 Reduced 26.56%	4,541 $459,000

Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $42,777 - $50,184	-450 Reduced 6.78%	6,183 $679,000
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $4,354 - $5,041	-45 Reduced 0.67%	6,633 $642,000
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $83,187 - $100,546	-815 Reduced 10.88%	6,678 $726,000
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $27,820 - $33,925	-244 Reduced 3.15%	7,493 $887,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $6,469 - $7,921	-56 Reduced 0.72%	7,737 $1.09 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $26,131 - $28,909	-224 Reduced 2.79%	7,793 $921,000
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $38,084 - $44,830	360 Added 4.7%	8,017 $929,000
Q1 2021 Aug 04, 2021	SELL	$108.84 - $128.23 $5,442 - $6,411	-50 Reduced 0.65%	7,657 $918,000
Q4 2020 Feb 01, 2021	BUY	$105.0 - $114.42 $11,970 - $13,043	114 Added 1.5%	7,707 $844,000
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $65,430 - $79,461	714 Added 10.38%	7,593 $826,000
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $1,531 - $1,960	-20 Reduced 0.29%	6,879 $629,000
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $4,837 - $7,073	-77 Reduced 1.1%	6,899 $544,000
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $51,895 - $57,771	-661 Reduced 8.66%	6,976 $606,000
Q3 2019 Oct 11, 2019	BUY	$81.84 - $88.74 $95,425 - $103,470	1,166 Added 18.02%	7,637 $639,000
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $9,765 - $11,390	-134 Reduced 2.03%	6,471 $544,000
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $4,635 - $5,604	-70 Reduced 1.05%	6,605 $528,000
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $24,191 - $27,405	369 Added 5.85%	6,675 $483,000
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $9,425 - $11,370	-155 Reduced 2.4%	6,306 $463,000
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $4,029 - $4,447	70 Added 1.1%	6,461 $394,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $1,406 - $1,590	-25 Reduced 0.39%	6,391 $383,000
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $201,783 - $216,029	-3,759 Reduced 36.94%	6,416 $366,000
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $489,010 - $545,787	10,175	10,175 $543,000

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.

Account

Camden National Bank Abbott Laboratories Transaction History